Suchergebnisse - "Cortesi, Laura"

PubPharm (19)

1

Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC) : retrospective multicentric analysis of post-progression treatments

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Valenza, C. | Trapani, D. | Gandini, S. | +15

2

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

enthalten in: Journal of the National Cancer Institute | 2022

von Barnes, D. | Silvestri, V. | Leslie, G. | +99

CommentIn: J Urol. 2022 Mar;207(3):735-738. - PMID 34915718

3

Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery : a prospective study

enthalten in: Menopause (New York, N.Y.) | 2021

von Grandi, G. | Sammarini, M. | Cortesi, L. | +6

4

Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers : what is going on in a region of northern Italy?

enthalten in: Maturitas | 2021

von Grandi, G. | Perrone, A. | Perrone, A. | +21

5

Breast cancer screening of mutation carriers in the era of COVID-19 pandemic

enthalten in: International journal of cancer | 2020

von Toss, A. | Lambertini, M. | Punie, K. | +2

6

Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Lambertini, M. | Ameye, L. | Hamy, A. | +34

CommentIn: J Clin Oncol. 2020 Dec 20;38(36):4352. - PMID 33125308

7

Postmenopausal hormone therapy in BRCA gene mutation carriers : to whom and which?

enthalten in: Expert opinion on drug safety | 2020

von Grandi, G. | Caroli, M. | Cortesi, L. | +3

8

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants : Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

enthalten in: JAMA oncology | 2020

von Silvestri, V. | Leslie, G. | Barnes, D. | +98

ErratumIn: JAMA Oncol. 2020 Nov 1;6(11):1815. - PMID 32910162

9

The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery : a prospective cohort, other biomarker controlled, study

enthalten in: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) | 2020

von Grandi, G. | Del Savio, M. | Sammarini, M. | +4

10

A regional population-based hereditary breast cancer screening tool in Italy : First 5-year results

enthalten in: Cancer medicine | 2020

von Cortesi, L. | Baldassarri, B. | Ferretti, S. | +21